文献速递中医内科中药与中成药合理使用

炙甘草汤对糖尿病心肌梗死损伤的保护作用及有效成分鉴定

The protective effects of Zhi-Gan-Cao-Tang against diabetic myocardial infarction injury and identification of its effective constituents.
PubMed 文献 · J Ethnopharmacol · 2023-02-23

本研究在糖尿病心肌梗死(DMI)小鼠模型和高糖缺氧诱导的H9c2心肌细胞损伤模型中评价炙甘草汤(ZGCT)的保护作用并筛选有效成分。结果显示ZGCT显著减小DMI小鼠心肌梗死面积、降低血清LDH水平,减轻心肌纤维排列紊乱和炎症细胞浸润;细胞实验表明ZGCT通过降低促凋亡因子Bax表达抑制心肌细胞凋亡,并通过抑制IκBα/NF-κB通路激活和iNOS表达抑制炎症反应。从6味中药中鉴定出8种有效成分可增强损伤心肌细胞活力,其中甘草酸在体内验证具有心脏保护作用。

要点

  • 炙甘草汤可减小糖尿病心肌梗死小鼠心肌梗死面积并降低血清LDH水平。
  • 炙甘草汤通过抑制心肌细胞凋亡和炎症反应发挥心脏保护作用。
  • 鉴定出8种有效成分,甘草酸在体内验证有心脏保护作用。

核心结论

  • 炙甘草汤通过抑制心肌细胞凋亡和减轻炎症反应保护糖尿病心肌梗死损伤。
  • 从炙甘草汤中鉴定出8种有效成分,甘草酸在体内验证具有心脏保护作用。

研究设计与样本

  • 体内实验采用DMI小鼠模型评价炙甘草汤对DMI损伤的作用。
  • 体外实验采用高糖和缺氧诱导的H9c2心肌细胞损伤模型进行效果评价和有效成分筛选。

主要发现

  • 炙甘草汤显著减小DMI小鼠心肌梗死面积并降低血清LDH水平。
  • 炙甘草汤减轻DMI小鼠心肌纤维排列紊乱和断裂、细胞消失及炎症细胞浸润。
  • 炙甘草汤通过降低促凋亡因子Bax表达抑制心肌细胞凋亡。
  • 炙甘草汤通过抑制IκBα/NF-κB通路激活和iNOS表达抑制炎症反应。
  • 8种来自6味中药的有效成分增强损伤心肌细胞活力,6种通过抗凋亡和/或抗炎发挥作用。

临床怎么用

  • 炙甘草汤可作为糖尿病合并心血管疾病并发症的潜在治疗方剂。
  • 甘草酸可作为炙甘草汤质量标志物研究的候选成分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Cardiovascular complications are highly prevalent in patients with diabetes. Zhi-Gan-Cao-Tang (ZGCT), a famous traditional Chinese medicine (TCM) prescription, can be used for the treatment of diabetes with cardiovascular disease complications. ZGCT is composed of nine Chinese herbs: the radix and rhizoma of Glycyrrhiza uralensis Fisch. (Gancao in Chinese, 12 g), the radix of Rehmannia glutinosa Libosch. (Dihuang in Chinese, 50 g), the radix and rhizoma of Panax ginseng C. A. Mey. (Renshen in Chinese, 6 g), the radix of Ophiopogon japonicus (L. f.) Ker-Gawl. (Maidong in Chinese, 10 g), the fructus of Ziziphus jujuba Mill. (Dazao in Chinese, 18 g), the fructus of Cannabis sativa L. (Maren in Chinese, 10 g), Donkey-hide gelatine (Ejiao in Chinese, 6 g), the ramulus of Cinnamomum cassia Presl (Guizhi in Chinese, 9 g), and the fresh rhizoma of Zingiber officinale Rosc. (Shengjiang in Chinese, 9 g). Many of these Chinese herbs are also used in other systems of medicine (Japan, India, European, etc.). However, the effects and effective constituents of ZGCT against diabetic cardiovascular disease remain unclear. AIM OF THE STUDY: This study aimed to investigate the protective effect of ZGCT against diabetic myocardial infarction (DMI) injury in vivo and in vitro and to identify the effective constituents of ZGCT. MATERIALS AND METHODS: The in vivo effect on DMI injury was evaluated in a DMI mouse model. The in vitro effect and effective constituent screening experiments were conducted in an H9c2 cardiomyocyte injury model induced by high glucose and hypoxia. RESULTS: It was found that ZGCT significantly reduced myocardial infarction size and serum lactate dehydrogenase (LDH) levels in DMI mice. Myocardial histopathological experiments showed that ZGCT alleviated the disordered arrangement and fracture of muscle fibers and cell disappearance and reduced inflammatory cell infiltration. Cellular experiments showed that ZGCT inhibited cardiomyocyte apoptosis by decreasing the expression of the proapoptotic factor Bax. In addition, it inhibited inflammatory reactions by suppressing the activation of the IκBα/NF-κB pathway and the expression of iNOS. Eight constituents from six Chinese herbs in the recipe of ZGCT were found to enhance the viability of injured cardiomyocytes, and six effective constituents played protective roles through anti-apoptotic and/or anti-inflammatory activities. In addition, one of the effective constituents, glycyrrhizic acid, was verified in vivo to have cardioprotective effect on DMI mice. CONCLUSIONS: The TCM prescription ZGCT protects against DMI by inhibiting cardiomyocyte apoptosis and reducing inflammatory reactions. Eight effective constituents of ZGCT were identified. This study provides a scientific basis for the clinical application of ZGCT and is valuable for quality marker research on this prescription.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Hu M, Li H, Ni S, et al. The protective effects of Zhi-Gan-Cao-Tang against diabetic myocardial infarction injury and identification of its effective constituents. J Ethnopharmacol. 2023. PMID: 36828197. doi:10.1016/j.jep.2023.116320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。